Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voermans, C.
Right arrow Articles by Gerritsen, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voermans, C.
Right arrow Articles by Gerritsen, W. R.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Transplantation
Right arrow Cell Adhesion and Motility
Right arrow Chemokines, Cytokines, and Interleukins
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 February 2001, Vol. 97, No. 3, pp. 799-804

TRANSPLANTATION

In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation

Carlijn Voermans, Marisha L. K. Kooi, Sjoerd Rodenhuis, Hans van der Lelie, C. Ellen van der Schoot, and Winald R. Gerritsen

From the Divisions of Medical Oncology and Biometrics, Netherlands Cancer Institute; CLB, Sanquin Blood Supply Foundation, Laboratory for Experimental and Clinical Immunology, and Department of Hematology, Academic Medical Center, University of Amsterdam; and Department of Medical Oncology, Division of Gene Therapy Program, University Hospital of Vrije Universiteit, Amsterdam, Netherlands.

To investigate whether the migratory ability of peripheral blood-derived CD34+ cells of patients undergoing autologous peripheral blood stem cell transplantation is related to the homing efficiency of these cells, the migration in vitro of these cells was determined and correlated with in vivo hematopoietic recovery. Large inter-individual differences of the in vitro migratory ability of the CD34+ cells were observed, ranging from 1.1% to 16.4% for spontaneous migration and 6.2% to 40.8% for SDF-1-induced (100 ng/mL) migration. Significantly faster hematologic recovery was observed in those patients who received transplanted CD34+ cells that showed high spontaneous and SDF-1-induced migration in vitro (P < .05). Moreover, CD34+ cells from healthy G-CSF-mobilized donors exhibited significantly higher spontaneous and SDF-1-induced (P < .01) migration than CD34+ cells from patients mobilized with chemotherapy and G-CSF. The lower migratory capacity in vitro of patient-derived CD34+ cells was not due to lower expression of CXCR-4 but probably reflected decreased motogenic behavior of the cells. These results indicate that the migratory capacity of the cells is important for hematopoietic recovery. The data suggest that the engraftment potential of autologous stem cells is more or less impaired by treatment before or during the mobilization procedure and might possibly be restored by in vitro manipulation of the cells. In addition, an exponential relation between CXCR-4 expression and number of CD34+ cells that mobilized to the peripheral blood was found (P < .001), suggesting that CXCR-4 expression plays a role in the mobilization of CD34+ cells.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. Lin, E. De Stanchina, X. K. Zhou, Y. She, D. Hoang, S. W. Cheung, B. Cassileth, and S. Cunningham-Rundles
Maitake Beta-Glucan Enhances Umbilical Cord Blood Stem Cell Transplantation in the NOD/SCID Mouse
Experimental Biology and Medicine, March 1, 2009; 234(3): 342 - 353.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Bogani, V. Ponziani, P. Guglielmelli, C. Desterke, V. Rosti, A. Bosi, M.-C. Le Bousse-Kerdiles, G. Barosi, A. M. Vannucchi, and for the Myeloproliferative Disorders Research Cons
Hypermethylation of CXCR4 Promoter in CD34+ Cells from Patients with Primary Myelofibrosis
Stem Cells, August 1, 2008; 26(8): 1920 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Voo, J. Eggermann, M. Dunaeva, C. Ramakers-van Oosterhoud, and J. Waltenberger
Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction
Eur. Heart J., January 2, 2008; 29(2): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Fukuda, H. Bian, A. G. King, and L. M. Pelus
The chemokine GRO{beta} mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment
Blood, August 1, 2007; 110(3): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al.
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor
Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 275 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. J. Lorenowicz, J. van Gils, M. de Boer, P. L. Hordijk, and M. Fernandez-Borja
Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis
J. Leukoc. Biol., December 1, 2006; 80(6): 1542 - 1552.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Goichberg, A. Kalinkovich, N. Borodovsky, M. Tesio, I. Petit, A. Nagler, I. Hardan, and T. Lapidot
cAMP-induced PKC{zeta} activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors
Blood, February 1, 2006; 107(3): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
K. Li, C. K. Y. Chuen, S. M. Lee, P. Law, T. F. Fok, P. C. Ng, C. K. Li, D. Wong, A. Merzouk, H. Salari, et al.
Small Peptide Analogue of SDF-1{alpha} Supports Survival of Cord Blood CD34+ Cells in Synergy with Other Cytokines and Enhances Their Ex Vivo Expansion and Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice
Stem Cells, January 1, 2006; 24(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. H. Walter, J. Haendeler, J. Reinhold, U. Rochwalsky, F. Seeger, J. Honold, J. Hoffmann, C. Urbich, R. Lehmann, F. Arenzana-Seisdesdos, et al.
Impaired CXCR4 Signaling Contributes to the Reduced Neovascularization Capacity of Endothelial Progenitor Cells From Patients With Coronary Artery Disease
Circ. Res., November 25, 2005; 97(11): 1142 - 1151.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Lapidot, A. Dar, and O. Kollet
How do stem cells find their way home?
Blood, September 15, 2005; 106(6): 1901 - 1910.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Samira, C. Ferrand, A. Peled, A. Nagler, Y. Tovbin, H. Ben-Hur, N. Taylor, A. Globerson, and T. Lapidot
Tumor Necrosis Factor Promotes Human T-Cell Development in Nonobese Diabetic/Severe Combined Immunodeficient Mice
Stem Cells, November 1, 2004; 22(6): 1085 - 1100.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Bonig, G. V. Priestley, L. M. Nilsson, Y. Jiang, and T. Papayannopoulou
PTX-sensitive signals in bone marrow homing of fetal and adult hematopoietic progenitor cells
Blood, October 15, 2004; 104(8): 2299 - 2306.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kimura, A. M. Boehmler, G. Seitz, S. Kuci, T. Wiesner, V. Brinkmann, L. Kanz, and R. Mohle
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells
Blood, June 15, 2004; 103(12): 4478 - 4486.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Tavor, I. Petit, S. Porozov, A. Avigdor, A. Dar, L. Leider-Trejo, N. Shemtov, V. Deutsch, E. Naparstek, A. Nagler, et al.
CXCR4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD/SCID Mice
Cancer Res., April 15, 2004; 64(8): 2817 - 2824.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Kahn, T. Byk, L. Jansson-Sjostrand, I. Petit, S. Shivtiel, A. Nagler, I. Hardan, V. Deutsch, Z. Gazit, D. Gazit, et al.
Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation
Blood, April 15, 2004; 103(8): 2942 - 2949.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine
Stem Cell Mobilization
Hematology, January 1, 2003; 2003(1): 419 - 437.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. B. Adams, K. T. Chabner, R. B. Foxall, K. W. Weibrecht, N. P. Rodrigues, D. Dombkowski, R. Fallon, M. C. Poznansky, and D. T. Scadden
Heterologous cells cooperate to augment stem cell migration, homing, and engraftment
Blood, January 1, 2003; 101(1): 45 - 51.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Kollet, I. Petit, J. Kahn, S. Samira, A. Dar, A. Peled, V. Deutsch, M. Gunetti, W. Piacibello, A. Nagler, et al.
Human CD34+CXCR4- sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation
Blood, September 26, 2002; 100(8): 2778 - 2786.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Narayanasami, R. Kanteti, J. Morelli, A. Klekar, A. Al-Olama, C. Keating, C. O'Connor, E. Berkman, J. K. Erban, K. A. Sprague, et al.
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation
Blood, October 1, 2001; 98(7): 2059 - 2064.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020